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INTRODUCTION
Activation-induced deaminase (AID) is a crucial enzyme 
for the immune response because it generates high-affinity 
and switched antibodies in germinal center (GC) B cells 
by somatic hypermutation (SHM) and class switch recom-
bination (CSR; Muramatsu et al., 2000; Revy et al., 2000). 
AID initiates SHM and CSR through the deamination of 
deoxycytidine residues into deoxyuridines on the DNA of Ig 
genes (Muramatsu et al., 2000; Petersen-Mahrt et al., 2002; 
Di Noia and Neuberger, 2007; Stavnezer et al., 2008). The 
resulting U:G mismatch can be alternatively recognized and 
processed by base excision repair (BER) or mismatch repair 
(MMR) pathways, leading either to point mutations, in the 
case of SHM, or to double-strand breaks (DSBs) followed 
by a recombination reaction, in the case of CSR (Di Noia 
and Neuberger, 2007; Stavnezer et al., 2008; Reynaud et al., 
2009; Methot and Di Noia, 2017). Although AID activity has 
a strong preference for Ig genes, it can also target other genes, 
giving rise to point mutations (Shen et al., 1998; Pasqualucci 
et al., 2001; Liu et al., 2008) or oncogenic chromosome trans-
locations (TCs; Ramiro et al., 2004, 2006; Robbiani et al., 
2008). Understanding AID specificity, or targeting, has been 
hindered by the technical challenge of detecting AID-induced 
mutations, which occur at very low frequencies. Here, we 
have used next generation sequencing to directly measure 
raw AID mutational activity on a broad representation of the 
genome and thus gather conclusions on AID specificity, DNA 
repair, and lymphomagenesis.
RESULTS AND DISCUSSION
Capture-based deep sequencing allows high-throughput 
identification of AID targets
To explore the scope of AID-induced mutations at a high- 
throughput scale, we designed a capture library against 1,588 
regions corresponding to 1,379 different genes as a representa-
tion of the B cell genome (Table S1; see Design of DNA capture 
library in the Materials and methods). Genomic DNA from GC 
B cells was isolated, captured, and deep sequenced (Fig. S1, A 
and B). We made use of a mouse model deficient for both BER 
and MMR pathways (Ung−/−Msh2−/− mice). In the absence 
of BER and MMR, AID-induced U:G mismatches remained 
unprocessed and were replicated over, thus leaving behind 
almost solely C→T and G→A transitions, the footprint of 
AID de amination events on DNA (Rada et al., 2004; Methot 
and Di Noia, 2017). This approach allowed an extremely ef-
ficient enrichment and sequencing depth (Fig. S1, A and 
B). We found a set of 291 genomic regions (corresponding 
to 275 different genes) that were reproducibly mutated in 
Ung−/−Msh2−/− GC B cells when compared with Aicda−/− 
GC B cells (q ≤ 0.05; Fig. 1 A; Fig. S1, C–E; and Table S2; 
representative targets were validated by Sanger sequencing; 
Fig. 1 B and Table S3). Importantly, the 275-gene target col-
lection included 30 of the 35 previously known AID targets, 
such as Bcl6, Pim1, RhoH, Pax5, and Cd83 (Fig.  1  C and 
Table S2; Pasqualucci et al., 2001; Liu et al., 2008; Methot and 
Di Noia, 2017). Mutations detected in the 291-target regions 
strongly accumulated in AID mutational hotspots (WRC(Y)/
(R)GYW; underlined letters specify deaminated nucleo-
tides; W = A/T; R = A/G; Y = C/T; Fig. 1 D; Rogozin and 
Kolchanov, 1992). Finally, we found that our 275-target set in-
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cluded a big proportion of genes subject to DSBs or chromosome 
TCs (Fig. S1 F; Chiarle et al., 2011; Klein et al., 2011; Stasze-
wski et al., 2011; Qian et al., 2014; Dong et al., 2015). Thus, our 
deep sequencing approach has allowed the discovery of an un- 
precedented, massive collection of AID targets.
Identification of AGCTNT as a novel AID hotspot
To gain insights into the local sequence preference of AID, 
we first analyzed the mean mutation frequency at individ-
ual WRCY/RGYW hotspots across all 291 AID targets and 
found a wide range of mutability, with AACT and AGCT 
Figure 1. High-throughput analysis of AID-induced mutations. DNA from Peyer's patch GC B cells was captured with a probe library for 1,588 ge-
nomic regions (Table S1) and deep sequenced. AID targets were identified as those regions accumulating significantly more C→T transition mutations in 
Ung−/−Msh2−/− than in Aicda−/− mice (Table S2; FDR ≤0.05, one-tail Fisher test and Benjamini-Hochberg correction; two independent experiments; see 
Materials and methods). (A) Circos plot representation of the AID targets identified in this study and their associated molecular features. The outer ring 
shows chromosome location and is followed by C→T transition mutation frequency in Ung−/−Msh2−/− (red) and Aicda−/− (gray) mice. (B) Validation of 
representative AID targets by Sanger sequencing (one-tail Fisher test; Table S3). (C) Overlap between the targets discovered in this study and previously 
reported AID targets. (D) Mean transition frequency in total C/G nucleotides and in C/G within WRC(Y)/(R)GYW hotspots (W = A/T; R = G/A; Y = C/T) of 
the 291 AID targets (two-tailed Student’s t test; two independent experiments). (E) Logo representation of the sequence context of mutated cytosines 
(mutation frequency ≥4 × 10−3). Statistically significant enrichment of nucleotides surrounding the mutated C is indicated (*, FDR ≤10−3, one-tail Fisher 
test and Bonferroni correction; see Materials and methods), and numbers indicate percentages. (F) Mean mutation frequency of cytosines within the indi-
cated motifs (dark blue bar, newly identified hotspot; gray bar, control motif for newly identified hotspot; light blue bars, WRCY hotspots; red bars, random 
four-nucleotide motifs; two-tailed Mann-Whitney test). *, P ≤ 0.05; ***, P < 10−3; ****, P < 10−4. Error bars depict SEM.
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as the top mutated hotspots in both strands of DNA, which 
may reflect an intrinsic preference for AID deaminase activ-
ity. Next, we performed an unbiased analysis of the sequence 
context of mutated cytosines. We found that A, G, and T nu-
cleotides were the preferred nucleotides at −2, −1, and +1 
positions (Pérez-Durán et al., 2012; Wei et al., 2015; Yeap et 
al., 2015), respectively, but we further uncovered a significant 
preference for T at +3 (Fig. 1 E and Fig. S2). Indeed, cytosines 
lying at the AGCTNT motif were significantly more mutated 
than those in AGCTNV (where V is A, C, or G) or than other 
WRCY/RGYW hotspots (Fig. 1 F and Fig. S2, A and B). 
Thus, our study has revealed AGCTNT as a novel and the 
most highly mutated AID hotspot identified so far.
Prediction of AID targets
Using the uniquely large set of AID-mutated genes identified 
in this study, we performed a comprehensive analysis of molec-
ular features that associate with SHM, including transcription, 
epigenetic marks, and regulatory sequences (Fig. 1 A; Storb, 
2014; Methot and Di Noia, 2017). We first observed that tran-
scription levels and transcription rates are significantly higher 
in AID targets than in nontargets and that this difference is 
even higher for highly mutated targets (Fig.  2  A). We also 
found that RNAPolII and the stalling factor Spt5, previously 
described to associate with AID (Nambu et al., 2003; Pavri 
et al., 2010), show higher binding density within AID muta-
tional targets (Fig. 2 B). Likewise, AID targets were enriched 
in marks of active enhancers and transcriptional elongation, 
such as Med12, H3K36me3, and H3K79me2 (Fig. 2 C). Fi-
nally, we found that primary AID targeting, as measured by 
AID mutations in the absence of repair, also focuses prefer-
entially in the vicinity of superenhancers (Fig. 2 D) and in 
regions subject to convergent transcription (Fig. 2 E; Meng 
et al., 2014; Qian et al., 2014). Together, our mutagenesis 
study shows that several mechanisms linked to transcription 
are critical for AID activity, as suggested in previous studies 
(Nambu et al., 2003; Pavri et al., 2010; Meng et al., 2014; 
Qian et al., 2014; Wang et al., 2014). Our data also indicate 
that AID targeting cannot be defined by any of these features 
alone. To approach whether a combination of these molecular 
features could be used to predict AID targeting, we developed 
a prediction model using a machine-learning algorithm, fed 
with the collection of genes analyzed here together with the 
set of molecular features described in Fig. 2 (A–E) (Fig. S3, 
A and B; see Machine learning to predict AID targets in the 
Materials and methods for details). We found that a combi-
nation of high-density RNAPolII and Spt5 binding, found 
in 2.3% of genes in the whole genome (Fig. S3 B), predicts 
AID specificity with 77% probability (P < 0.001; Fig.  2  F 
and Fig. S3 A). Conversely, low RNAPolII binding combined 
with low gene expression predicted the absence of muta-
tions for 95% of genes (Fig. 2 F). To test the accuracy of our 
prediction model, we analyzed the mutation frequency of a 
new collection of genes (not included in our capture library) 
with high-density RNAPolII and Spt5 binding (Fig. S3 C 
and Table S4). We found that 11/12 of the analyzed genes 
were significantly mutated (Table S4 and Fig. 2 G). Indeed, 
two genes (Hist1h1c and Clec2d) were mutated at the range 
of the top 20% mutated genes at frequencies similar to those 
found in Pax5 or Rhoh (Table S2 and Table S4). Thus, we 
have built a powerful predictive tool for AID activity.
BER and MMR back up each other to faithfully 
repair AID-induced lesions
BER and MMR act downstream of AID-induced U:G 
mismatches so that UNG is critical for the generation of 
transversions at C:G pairs while MSH2 facilitates the intro-
duction of mutations at A:T pairs (Frey et al., 1998; Phung 
et al., 1998; Rada et al., 1998, 2002, 2004; Methot and Di 
Noia, 2017). UNG and MSH2 can also promote conven-
tional, faithful repair of AID-induced U:G mismatches (Liu 
et al., 2008; Pérez-Durán et al., 2012). To explore the con-
tribution of BER and MMR to AID mutagenic activity, we 
analyzed GC B cells from single-deficient Ung+/−Msh2−/− 
and Ung−/−Msh2+/− mice and from control Ung+/−Msh2+/− 
mice and compared the mutation frequency of the 291 AID 
target regions identified in this study (Table S2). We found 
similar mean mutation frequencies in B cells deficient for 
UNG alone, MSH2 alone, or proficient for both, whereas 
AID targets harbored significantly more mutations in the 
combined absence of UNG and MSH2 (Fig.  3, A and B). 
Indeed, only a small proportion (∼6%) of the genes mutated 
in Ung−/−Msh2−/− cells was also mutated in single-knockout 
and double-heterozygous cells (Fig. 3 C and Table S2). More-
over, we found that classical AID off targets, such as Bcl6 or 
Pim1, although mutated in all genotypes analyzed, harbored a 
significantly bigger load of mutations in Ung−/−Msh2−/− cells 
than in Ung+/−Msh2−/−, Ung−/−Msh2+/−, or Ung+/−Msh2+/− 
cells (Fig. 3 D). Together, these data indicate that BER and 
MMR back up each other to faithfully repair most of the 
AID-induced lesions in GC B cells.
AID targets are recurrently mutated in human lymphomas
We next assessed the contribution of AID off-target muta-
tions to B cell–derived malignancies by making use of avail-
able sequencing data on human lymphomas. We found that 
AID targets are significantly enriched in genes mutated in 
human B cell lymphomas (see Annotation of AID targets 
in the Materials and methods for details; Fig. 4 A). Indeed, 
21/275 (7.6%) of our set of AID target genes are mutated in 
diffuse large B cell lymphomas (DLB CLs; Fig. 4 B), a highly 
prevalent, aggressive form of lymphoma (Shaffer et al., 2012). 
Lymphoma genes mutated by AID included Bcl6, RhoH, 
Pim1, Ebf1, Eif4a2, and Pax5, which is in agreement with 
previous studies (Shen et al., 1998; Pasqualucci et al., 2001; 
Liu et al., 2008). In addition, we identified nine novel genes 
mutated in human DLB CLs that accumulate AID-induced 
mutations (Fig. 4 B), including Mef2b, Lyn, Tnfaip3, Gna13, 
and Irf8. Remarkably, we found many instances where the 
exact same mutations described in human lymphoma genes 
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were also found in the AID targets identified in this study 
in nontransformed mouse B cells (Fig.  4 C and Table S5). 
Together, these results suggest that off-target AID mutagenic 
activity can contribute to GC-associated lymphomagenesis.
Until now, the study of AID specificity has been hin-
dered by the technical challenge of detecting AID-induced 
mutations; indeed, only a limited number of genes has been 
directly interrogated for AID-mediated mutagenesis (Pasqua-
lucci et al., 2001; Liu et al., 2008; Methot and Di Noia, 2017). 
However, genome-wide AID specificity has been inferred 
from high-throughput analysis of AID binding, which does 
not warrant AID activity, AID-induced DSBs, or chromo-
somal TCs, which involve complex processing of the initial 
lesion induced by AID (Chiarle et al., 2011; Klein et al., 2011; 
Staszewski et al., 2011; Yamane et al., 2011; Meng et al., 2014; 
Qian et al., 2014). The strategy developed in this study has 
provided an unprecedented scope to the analysis of AID tar-
geting: we describe here the broadest collection of AID mu-
tational targets (275 genes) to date, 10-fold larger than the 
previously known targets. The strength of this analysis is well 
supported by the confirmation of the vast majority of previ-
ously identified AID targets and the validation of targets by 
conventional Sanger sequencing.
Here, we have integrated our mutation data with a collection 
of molecular features of GC B cells to feed a machine-learning 
algorithm. According to the machine-learning tree gener-
ated here, the combined binding of Spt5 and RNAPolII at 
high density is the best predictor for AID mutability, although 
Figure 2. Molecular features of AID targets predict mutability. (A) Expression level of highly mutated (top 20% mutated genes, C→T transition 
frequency >3 × 10−4), mutated (rest of mutated), and nonmutated genes in Peyer's patch GC B cells as measured by RNA-Seq and transcription rate of AID 
targets in GC B cells from lymph nodes as measured by GRO-Seq. TPM, transcripts per million. (B) Recruitment of RNAPolII and Spt5 to AID targets and 
nontargets measured in in vitro activated splenic B cells by ChIP-Seq. RPKM, reads per kilobase per million reads mapped. (C) Transcription and transcription 
elongation marks in AID targets and nontargets by ChIP-Seq analysis of in vitro activated splenic B cells (Med12, H3K4me1, H3K36me3, and H3K79me2). (D) 
Proportion of highly mutated, mutated, and nonmutated genes regulated by superenhancers (SE) in GC B cells (see Materials and methods). (E) GRO-Seq 
analysis of convergent transcription (ConvT) in AID targets and nontargets from GC splenic B cells obtained from SRBC-immunized mice. (F) Representation 
of the machine-learning approach used for AID target prediction. (G) Validation of representative genes predicted to be mutated by the model by PCR-Seq. 
Statistical tests: two-tailed Student’s t test (A, B, and G) and one-tailed Fisher test (C–E). ***, P < 10−3; ****, P < 10−4.
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additional combinations of transcriptional traits bear some 
predictive power as well. Furthermore, we have performed 
independent experimental validation showing that randomly 
picked Spt5highRNAPolIIhigh genes indeed are very frequently 
mutated by AID. This is, to our knowledge, the first instance of 
a tool that successfully predicts the potential of a gene to be tar-
geted by AID. Regarding the fate of AID-induced lesions, BER 
and MMR have long been known to broaden the diversity of 
SHM with an apparent perverted recruitment of error-prone 
polymerases and to do so in a cooperative manner (Rada et 
al., 2004; Di Noia and Neuberger, 2007; Methot and Di Noia, 
2017). The mechanisms responsible for the error-free versus 
error-prone activity of UNG and MSH2 are far from un-
derstood, and both gene-specific and local sequence contexts 
may play a role in defining the fate of the U:G resolution (Liu 
et al., 2008; Pérez-Durán et al., 2012; Wei et al., 2015). Strik-
ingly, here we show that the fate of the majority of off-target 
lesions induced by AID is to undergo faithful repair by BER 
and MMR and that, again, both pathways can back up each 
other in this task with only a minor fraction of the mutations 
escaping them. Whether this reflects gene-specific qualities or 
is the consequence of excessive mutation load will deserve fur-
ther investigation. We would speculate that a minor fraction 
of unrepaired mutations in prolymphomagenic genes could 
provide cell growth advantage and account for the predomi-
nance of AID-mediated mutations in lymphomas. Regardless 
of oncogenic relevance, it is remarkable that even though our 
mutation analysis was performed in nontransformed cells, we 
could detect individual AID-induced mutations that are recur-
rently mutated in lymphoma. Thus, our results yield a novel 
perspective on the contribution of AID activity to B cell trans-
formation through the introduction of mutations.
Figure 3. BER and MMR back up each other to error-free repair AID-induced lesions. (A and B) Total mutation frequency of AID targets in 
Ung+/−Msh2+/−, Ung−/−Msh2+/−, and Ung+/−Msh2−/− GC B cell mice compared with that of Ung−/−Msh2−/− mice (mean of two independent experiments; see 
Materials and methods; Table S2). (C) Heat map representation of AID targets in Ung+/−Msh2+/−, Ung−/−Msh2+/−, Ung+/−Msh2−/−, and Ung−/−Msh2−/− GC B 
cells. (D) Mutation frequency of representative genes in Ung+/−Msh2+/−, Ung−/−Msh2+/−, Ung+/−Msh2−/−, Ung−/−Msh2−/−, and Aicda−/− GC B cells. Red dots 
indicate statistically different mutation frequencies between the indicated genotypes. Mutation frequency found in Aicda−/− mice was substracted before 
plotting A–C. (A and D) Two-tailed Student’s t test; *, P ≤ 0.05. Error bars depict SEM. N.S., not significant.
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We expect our mutational study will be valuable for 
other research questions, including validation of novel mo-
lecular mechanisms involved in AID targeting, prediction of 
novel targets, or assessment of cancer-associated mutations. 
Furthermore, similar approaches would be of immediate in-
terest to broaden our knowledge on the role of AID or other 
mutagenic activities not only in B cell lymphomas, but also in 
malignancies from any origin.
MATERIALS AND METHODS
Mice
Ung and Msh2 mutant mice used in this study were generated 
by crossing Ung−/− mice (Nilsen et al., 2000) and Msh2−/− 
mice (Reitmair et al., 1995). Aicda−/− mice have been previ-
ously described (Muramatsu et al., 2000). Mice were housed 
in specific pathogen-free conditions. Male and female mice 
between 20 and 28 wk were used for the experiments. The 
number of animals per group to detect biologically signifi-
cant effect sizes was calculated using an appropriate statistical 
sample size formula. All experiments were done in concor-
dance with EU Directive 2010/63EU and Recommendation 
2007/526/EC regarding the protection of animals used for 
experimental and other scientific purposes, enforced in Span-
ish law under RD 53/2013.
Design of DNA capture library
A set of 1,379 mouse genes was selected as a representation 
of the genome (Table S1). 85% of all genes were randomly 
picked, ensuring even representation of chromosomal loca-
tion by bioinformatic analysis and unbiased biological func-
tion. ∼15% of the library corresponded to previously known 
AID targets (Müschen et al., 2000; Pasqualucci et al., 2001; 
Gordon et al., 2003; Liu et al., 2008; Robbiani et al., 2009; 
Pavri et al., 2010), IgH probes, and other controls. Probes 
were designed in eArray (Agilent) to capture the first 500 bp 
downstream of each transcriptional start site (TSS) of each of 
the 1,379 genes. Because various genes contained more than 
one predicted TSS, the library includes a total of 1,588 dif-
Figure 4. AID targets are recurrently mutated 
in human lymphomas. (A) AID targets are enriched 
in genes involved in lymphoma development. Per-
centage of lymphoma genes within AID target and 
nontarget genes. Annotation was done from public 
data on human lymphoma sequencing (see Materials 
and methods; two-tailed Fisher test; ****, P < 10−4). 
(B) Mutation frequency in total C/G nucleotides and 
C/G nucleotides within WRC(Y)/(R)GYW hotspots (W 
= A/T; R = G/A; Y = C/T) of the 21 AID target genes 
involved in human DLB CL development analyzed 
in Ung−/−Msh2−/− mice (mean of two independent 
experiments; see Materials and methods). (C) Muta-
tion profiles of representative DLB CL genes analyzed 
in Ung−/− Msh2−/− mice. Blue bars indicate muta-
tions identical to those found in human lymphoma 
tumor samples (Table S5); asterisks indicate muta-
tions occurring in a WRC(Y) hotspot. The diagrams 
below the graphs represent the complete gene (not 
to scale), and blue boxes indicate the region depicted 
above. Mutation frequency found in each nucleotide 
in Aicda−/− mice was subtracted before plotting.
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ferent genomic regions. Library design included 50 extra nu-
cleotides at both ends of each region to optimize the capture 
yield. A custom target enrichment capture library was then 
synthesized by the manufacturer (SureSelectXT; Agilent).
DNA capture and sequencing
GC (Cd19+Fas+GL7+) B cells were isolated from Peyer’s 
patches of Ung+/−Msh2+/− (n1 = 10; n2 = 11), Ung−/−Msh2+/− 
(n1 = 46; n2 = 8), Ung+/−Msh2−/− (n1 = 46; n2 = 2), and 
Ung−/−Msh2−/− (n1 = 37; n2 = 8) littermates and Aicda−/− (n 
= 31 mice) mice by sorting in a FAC SAria cell sorter (BD 
Biosciences) after staining with anti–mouse antibodies to 
Cd19, Fas, and GL7 (BD Biosciences). Genomic DNA was 
isolated by standard procedures and quantified in a fluorome-
ter (Qubit; Invitrogen). DNA capture, library preparation, and 
DNA sequencing were performed by the Genomics Unit at 
Centro Nacional de Investigaciones Cardiovasculares (CNIC). 
In brief, DNA was fragmented in a sonicator (Covaris) to 
∼200 nucleotide-long (mean size) fragments and purified 
using AMPure XP beads (Agencourt). Quality was assessed 
with the 2100 Bioanalyzer (Agilent). Then, fragment ends 
were repaired, adapters were ligated, and the resulting library 
was amplified and hybridized with our custom SureSelectXT 
library of RNA probes. DNA–RNA hybrids were then cap-
tured by magnetic bead selection. After indexing, libraries were 
single-end sequenced in a HiSeq 2500 platform (Illumina).
Target enrichment assessment by quantitative RT-PCR
Noxa1, Ostn, and Pcna amplifications were quantified with 
green assay (SYBR; Applied Biosystems) in a real-time PCR 
system (AB7900 Standard; AbiPrism). Gapdh amplifications 
were used as normalization controls. The following prim-
ers were used: Gapdh (forward), 5′-TGA AGC AGG CAT CTG 
AGGG-3′; Gapdh (reverse), 5′-CGA AGG TGG AAA GTG 
GGAG-3′; Ostn (forward), 5′-CAT AGT GTT GCT GTG GTT-
3′; Ostn (reverse), 5′-CAT TAT ATT GGT CTG CTG TT-3′; 
Noxa1 (forward), 5′-CGC GGG ACA GCA ATG AGA AG-3′; 
Noxa1 (reverse), 5′-CCA TCT ACT CAG TTT CAA GGA-3′; 
Pcna (forward), 5′-CTC CAG CAC CTT CTT CAG-3′; and 
Pcna (reverse), 5′-TCT CAT CTA GTC GCC ACA-3′.
SDS software (Applied Biosystems) was used 
for analysis of the data.
Sanger sequencing
Regions to be sequenced were amplified from 160–200-
ng genomic DNA in four independent reactions to mini-
mize possible PCR biases. The following primers were used: 
Hist1h1b (forward), 5′-ATG CCT TAG ACT TCA CCG CC-
3′; Hist1h1b (reverse), 5′-TTG TAA CCT TGA GTC GCC 
GC-3′; miR142 (forward), 5′-CGG TCC CTG GGA AGT 
TAC AC-3′; miR142 (reverse), 5′-AAC GAG AGG CAA ACA 
GTC TTCA-3′; Cd19 (forward), 5′-GCC CCT CTT CCC 
TCC TCA TA-3′; Cd19 (reverse), 5′-CCT GCA CCC ACT 
CAT CTG AA-3′; Cdk4 (forward), 5′-TCT GGC AGC TGG 
TCA CAT GG-3′; and Cdk4 (reverse), 5′-GAT CAC CAG 
CTA GTC GTC CC-3′. Amplification reactions were car-
ried in a final volume of 25 µl using 2.5 U Pfu Ultra HF 
DNA polymerase (Agilent) and the following PCR setup: 
95°C for 2 min, 25 (Cd19 and Cdk4) or 26 cycles (miR142 
and Hist1h1b) of denaturation at 94°C for 30 s, annealing at 
57°C (miR142 and Hist1h1b) or 58°C (Cd19 and Cdk4) 
for 30  s, extension at 72°C for 1 min, and a final stage of 
72°C for 10 min. PCR products were purified from a 1% 
agarose gel (Illustra Gel Band Purification kit; GE Health-
care) and cloned into pGEMT vector (Promega). Competent 
DH5α Escherichia coli bacteria were transformed with the 
constructs, and individual colonies (192–288 per gene) were 
grown in 96-well plates. Plasmidic DNA was then isolated 
(Plasmid MiniPrep kit; Millipore) and sequenced by Sanger 
sequencing using SP6 universal primer. Sequence analysis was 
performed using SeqMan software (Lasergene).
PCR-Seq to validate the machine-learning approach
40–50 ng of genomic DNA was amplified using the follow-
ing primers: Apobec3 (forward), 5′-GTC TTC CAT AGC CTG 
CTC ACA-3′; Apobec3 (reverse), 5′-TAG CTG ACT GGT 
GTG GTT CC-3′; Aurkaip1 (forward), 5′-ACT TGT CAC 
TTC CGC AGT CC-3′; Aurkaip1 (reverse), 5′-CCA TCC 
CCA AGT CAG GTG TG-3′; Ccdc17 (forward), 5′-TCT TTT 
CTG TCC AGT CCG CC-3′; Ccdc17 (reverse), 5′-ACA AAT 
GGG CAG AGT CAG GG-3′; Cd52 (forward), 5′-TAC TGC 
CGC ACA CAT GAC TC-3′; Cd52 (reverse), 5′-TGA GGT 
GGG AAG CCA AAC AT-3′; Cd68 (forward), 5′-AGG GGC 
TGG TAG GTT GAT TG-3′; Cd68 (reverse), 5′-GGA GTC 
AGG ACT GGA TTT GAC-3′; Cd69 (forward), 5′-TCT 
AAA GGT TTT GAG ACC CCC-3′; Cd69 (reverse), 5′-
TGA AGC CTC ATC AAC GCA CT-3′; Clec2d (forward), 
5′-GGC TCC TGA CCT TGA AAT GC-3′; Clec2d (re-
verse), 5′-AGG CAA CTT CTG CCA CTA TGC-3′; Coro1a 
(forward), 5′-AGG GCT CTG GGG TTC TAC TT-3′; Co-
ro1a (reverse), 5′-GGA AAT GAC CAC GGG GGT TT-3′; 
Hist1h1c (forward), 5′-CTC TAT CGG CGT ACT GCC AC-
3′; Hist1h1c (reverse), 5′-ATC GAG TCC CTT GCA ACC 
TT-3′; Il4i (forward), 5′-ATT CCC GAG GGA GGT GAG 
TG-3′; Il4i (reverse), 5′-GGT AGC TTC TCT CCG TCA 
CAC-3′; Maz (forward), 5′-GTC AAC AAA GAA CCC CTC 
CCT-3′; Maz (reverse), 5′-CAC CTG TCC CCT GAG TTG 
TG-3′; Trex1 (forward), 5′-GCC TAA CAG GTT TGA TTG 
TCC T-3′; and Trex1 (reverse), 5′-TAG GCT GAG CAC 
TCC CAG TC-3′. Amplification reactions were carried in a 
final volume of 25 µl using 2.5 U Pfu Ultra HF DNA poly-
merase (Agilent; 95°C for 2 min, 26 cycles of 94°C for 30 s, 
55°C for 30  s, 72°C for 1 min, and a final stage of 72°C 
for 10 min). PCR products were purified and fragmented 
using a sonicator (Covaris), and libraries were prepared by 
the CNIC Genomics Unit according to the manufacturer’s 
instructions (NEBNext Ultra DNA Library Prep; New En-
gland Biolabs). Sequencing was performed in a HiSeq 2500 
platform (Illumina). Analysis was performed as previously 
described (Pérez-Durán et al., 2012).
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Gene expression profiling by RNA-Seq
GC (CD19+Fas+GL7+) and resting (CD19+Fas−GL7−) B 
cells were sorted from Peyer’s patches of littermate 12-wk-
old WT C57BL/6 mice. Three biological replicates were 
analyzed, each composed of a pool of five female mice. 
RNA was purified from pellets of 2–2.5 × 104 cells, and 
DNaseI treatment was applied to avoid DNA contamina-
tion (RNAeasy MiniKit; Qiagen). RNA quality was assessed 
with the 2100 Bioanalyzer, showing high RNA purity and 
integrity. Sequencing libraries were prepared by the CNIC 
Genomic Unit according to the manufacturer’s protocol 
(NEB NEXT Ultra RNaseq Library Prep kit; New England 
Biolabs) from 100 ng RNA per replicate and sequenced 
in a HiSeq 2500 platform.
Computational analysis
Pipeline to identify and annotate AID-induced mutations. 
Raw reads were demultiplexed by Casava v1.8 to generate a 
fastq file that was aligned to the mouse genome (NCBIm37 
v61 Feb 2011) with Novoalign 2.08.01 (command line op-
tions: -o SAM -F ILM1.8 -H -r None -q 2). Sam files were 
processed with Samtools 0.1.19 to generate a sorted bam file 
that was piped to a custom Perl script for the analysis of AID 
mutations. In brief, the software analyzes the regions of inter-
est in the bam file, annotates hotspots, localizes and suppresses 
annotated single nucleotide polymorphism positions (Sanger 
Mouse Genomes Project SNP and Indel Release v2), and 
reports relevant information about AID activity. AID targets 
were identified as those genes accumulating significantly 
more C→T transition mutations in Ung−/−Msh2−/− than in 
Aicda−/− mice (false discovery rate [FDR] ≤0.05, one-tail 
Fisher test and Benjamini-Hochberg correction).
Mutation frequencies were calculated as follows:
  Total mutation freq =  Total number of mutations  ___________________Total sequenced length , 
  Mutation freq  C/G =  
 ( Mutated cytosines + Mutated guanines ) 
   _______________________________ 
 ( Seq length cytosines + Seq length guanines ) , 
and
  
 Mutation freq  WRC ( Y ) / ( R ) GYW   =
   
 
 ( Mutated cytosines WRC ( Y )  +  Mutated guanines  ( R ) GYW )     _______________________________________  
 ( Seq length cytosines WRC ( Y )  +  Seq length guanines  ( R ) GYW ) 
.
 
(Only cytosines in WRC(Y) and guanines in 
(R)GYW were considered to calculate mutation 
frequency at hotspots.)
Integration of AID targets with public data on TC and DSB 
occurrence. The bar graph included in Fig. S1 F represents 
overlaps in the 1,375 genes analyzed in this study (divided 
into mutated and nonmutated genes) and genes where TCs or 
DSBs occur in B cells: Meng et al. (2014) refer to TC sites 
identified by HTG TS in αCD40+IL4-activated B cells as 
published in Table S2 from their study; Klein et al. (2011) refer 
to TC sites identified by TC-Seq in IgHI-Sce LPS+IL4-activated 
B cells as published in Table S4 from their study; Chiarle et al. 
(2011) refer to TC sites identified by HTG TS in c-myc25xI-SceI 
αCD40+IL4-activated B cells as published in Table S3 (signif-
icant hits at P ≤ 0.05) from their study; Qian et al. (2014) refer 
to DSBs identified by replication protein A (RPA) differential 
recruitment (RPA–chromatin immunoprecipitation [ChIP]) 
in IgkAID 53BP1−/− in vitro activated B cells as published in 
Table S1 A from their study; and Staszewski et al. (2011) refer 
to DSBs identified by Nbs1 binding (ChIP-on-ChIP) in 
LPS+αIgD-dextran+BLySS-activated B cells as published in 
Table S1 (P ≤ 0.05) from their study.
Sequence context of mutated cytosines. The sequence con-
text of mutated cytosines (C→T transition frequency ≥4 × 
10−3) was analyzed in a window of 10 nucleotides. Logo rep-
resentation was done using WebLogo3, and the percentage of 
each nucleotide in each position surrounding the mutated 
cytosine was calculated by a custom Perl script. Enrichment 
for adenosine, guanine, cytosine, or thymine was tested against 
the sequence context of all cytosines present in the 1,588 re-
gions analyzed in this study (one-tailed Student’s t test + 
Bonferroni correction).
Gene expression profiling by RNA-Seq. After demultiplexing 
by Casava v1.8, read quality was assessed by FAS TQC, and 
sequencing adapters were removed from sequence reads by 
cutadapt v1.9. The resulting reads were aligned to and quan-
tified on the mouse transcriptome (NCBIm38 v75, Feb 
2014) using RSEM v1.2.25 with the following parameters: -p 
3–time–output-genome-bam–sampling-for-bam–bowtie-e 
60–bowtie-m 30–bowtie-chunkmbs 512–fragment-length- 
mean 180–fragment-length-sd 50.
Transcription rate analysis (GRO-Seq). Reads were mapped 
to the mouse genome (mm9/NCBI37) using bowtie2, and 
uniquely mapped, nonredundant reads were kept. Reads 
mapping in ±1 kb from TSSs were quantified and summa-
rized at the gene level using HTSeq.
PolII and Spt5 recruitment. Quantification of PolII and Spt5 
recruitment was extracted from Table S3 A in Pavri et al. (2010).
Superenhancer analysis. Data were extracted from the catalog 
of superenhancers that overlap with gene bodies identified in 
GC B cells as published in Table S3 in Meng et al. (2014) 
(GEO accession no. GSE62296).
Epigenetic mark analysis. Sequencing data (fastq files) for 
each epigenetic mark were aligned to the mouse genome 
(NCBIm37 v61, Feb 2011) using bowtie 1.1.1 (command 
line options:–best -m1 -n2 -p2). Alignment files were pro-
cessed by Samtools 0.1.19 to generate a sorted bam file. Peak 
calling was done using MACS2 (v2.1.0.20140616) according 
to the optimal parameters for a histone modification status 
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profiling as reported by the creators of the tool (Feng et al., 
2011). Mapping of annotated peaks to genes was done 
using GRE AT (version 3.0.0).
Convergent transcription analysis (GRO-Seq). Convergent 
transcription data analysis was performed as described in 
Meng et al. (2014). In brief, reads were mapped to the mouse 
genome (mm9/NCBI37) using bowtie2, and uniquely 
mapped, nonredundant reads were kept. HOM ER (v4.6) was 
used with default parameters to identify transcribed regions 
from both strands and bedtools (v2.24) to find and annotate 
ConvT regions (regions where >100 bp of sense and anti-
sense transcription overlap occurs).
Machine learning to predict AID targets. The conditional in-
ference tree for classification was built using the ctree func-
tion from the party R package with default parameters. Genes 
with a background mutation frequency >5 × 10−4 were ex-
cluded to avoid artifacts. The following variables were fed into 
the model for each of the 1,339 genes analyzed: expression, 
transcription rate, PolII recruitment, and Spt5 recruitment 
(quantitative, continuous); Med12 recruitment, H3K4me1 re-
cruitment, H3K36me3 recruitment, H3K79me2 recruitment, 
regulation by superenhancers, and occurrence of convergent 
transcription (qualitative, discrete). All variables were assigned 
equal weights to fit the model.
Annotation of AID targets. Annotation of AID targets was 
performed based on public data on sequencing of human 
DLB CLs, Burkitt lymphomas, and follicular lymphoma tu-
mors (Lohr et al., 2012; Love et al., 2012; Morin et al., 2013; 
Zhang et al., 2013; de Miranda et al., 2014; Okosun et al., 2014).
Data availability
Sequencing data generated for this study are avail-
able through the GEO database: targeted DNA deep se-
quencing (accession no. GSE102944) and RNA-Seq 
(accession no. GSE98086).
The rest of the datasets analyzed in the current study are 
publicly available through the GEO and/or Sequence Read 
Archive: GRO-Seq (accession no. GSE62296), GC B cells (ac-
cession nos. SRR1611832, SRR1611833, and SRR1611834), 
naive B cells (accession nos. SRR1611829, SRR1611830, 
and SRR1611831), ChIP-Seq of PolII and Spt5 (accession 
no. GSE24178), and ChIP-Seq data of epigenetic marks 
Med12 (accession no. SRX347810), H3K4me1 (accession no. 
SRX347815), H3K36me3 (accession no. SRX185869), and 
H3K79me2 (accession no. SRX185843).
Statistical analysis
Statistical analyses were performed with stats R package 
v3.1.1. Error bars in figures represent SEM. Student’s t test was 
applied to continuous data, and a Fisher test was used to assess 
differences between categorical variables. P-values were cor-
rected for multiple hypothesis testing by Benjamini-Hochberg 
or Bonferroni method where appropriate. Differences were 
considered statistically significant at P ≤ 0.05 or q ≤ 0.05.
Online supplemental material
Fig. S1 shows the experimental workflow used to identify 
AID targets and technical controls. Fig. S2 shows mutation 
analysis of WRCY/RGYW hotspots. Fig. S3 shows details 
on the machine-learning classification tree used for the pre-
diction of AID targets. Table S1 contains a list of the genes 
included in the capture library. Table S2 A contains a de-
tailed mutation analysis of AID targets in Ung+/−Msh2+/−, 
Ung−/−Msh2+/−, Ung+/−Msh2−/−, and Ung−/−Msh2−/−. Table 
S2 B contains a list of the 18 AID targets mutated in re-
pair-proficient GC B cells. Table S3 shows mutation analy-
sis of genes validated by Sanger sequencing. Table S4 shows 
mutation analysis of the genes selected for machine-learning 
validation. Table S5 contains a list of the mutations found 
in Ung−/−Msh2−/− GC B cells that have been identified in 
cohorts of human lymphoma patients.
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